Literature DB >> 1487604

Monitoring of serum markers for fibrosis during CCl4-induced liver damage. Effects of anti-fibrotic agents.

Z Jiang1, D Y You, X C Chen, J Wu.   

Abstract

Liver fibrosis was induced in rats by repeated peritoneal injections of carbon tetrachloride (CCl4) over a period of 2-11 weeks. Serum procollagen III peptide (SPIIINP), prolidase (SP) and alanine aminotransferase (SALT) levels were monitored during the period of induction. The extent of fibrosis was semi-quantitatively estimated after collagen staining, and the anti-fibrotic effects of 16,16-dimethyl prostaglandin E2 (DMPGE2), colchicine, and zinc sulphate were studied. SPIIINP and SP were increased the first 2 weeks after CCl4 administration and peaked at 6 weeks. Alterations in SPIIINP and SP correlated well to the semi-quantitative histological score of liver sections during the first 6 weeks, and SP was positively related to SPIIINP throughout the whole induction period. DMPGE2 decreased SPIIINP, SP and SALT significantly in addition to a markedly decreased formation of liver collagens. Colchicine had a similar but less dramatic effect, whereas zinc sulphate only reduced SPIIINP without influencing liver damage. In conclusion SPIIINP seems to be a valuable indicator of liver fibrogenesis, and SP may play a limited role in indicating accelerated collagen metabolism in the liver. DMPGE2 obviously inhibited the production of collagens induced by CCl4. Colchicine also had an apparent effect on liver fibrosis, whereas zinc sulphate merely seemed to postpone it.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1487604     DOI: 10.1016/s0168-8278(05)80658-0

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  12 in total

1.  B cells: no longer bystanders in liver fibrosis.

Authors:  Rashpal K Bhogal; Constantin A Bona
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

2.  Colchicine therapy for hepatic murine schistosomal fibrosis: image analysis and serological study.

Authors:  A A Badawy; N M el-Badrawy; M M Hassan; F A Ebeid
Journal:  Int J Exp Pathol       Date:  1999-02       Impact factor: 1.925

3.  Animal experiment and clinical study of effect of gamma-interferon on hepatic fibrosis.

Authors:  H L Weng; W M Cai; R H Liu
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

4.  Prolidase could act as a diagnosis and treatment mediator in lung fibrosis.

Authors:  Ibrahim Türkbeyler; Tuncer Demir; Yavuz Pehlivan; Davut Sinan Kaplan; Ali Osman Ceribasi; Mustafa Orkmez; Nurten Aksoy; Seyithan Taysi; Bunyamin Kisacik; Ahmet Mesut Onat
Journal:  Inflammation       Date:  2012-10       Impact factor: 4.092

Review 5.  Animal models of alcoholic liver disease.

Authors:  Gavin E Arteel
Journal:  Dig Dis       Date:  2011-04-27       Impact factor: 2.404

6.  Serum prolidase and IGF-1 as non-invasive markers of hepatic fibrosis during four different periods after bile-duct ligation in rats.

Authors:  Orhan Tarçin; Nursal Gedik; Berna Karakoyun; Veysel Tahan; Gagan Sood; Ciğdem Celikel; Nurdan Tözün
Journal:  Dig Dis Sci       Date:  2007-11-13       Impact factor: 3.199

7.  Comprehensive characterization of serum clinical chemistry parameters and the identification of urinary superoxide dismutase in a carbon tetrachloride-induced model of hepatic fibrosis in the female Hanover Wistar rat.

Authors:  Rosemary Smyth; Michael R Munday; Malcolm J York; Christopher J Clarke; Theo Dare; John A Turton
Journal:  Int J Exp Pathol       Date:  2007-10       Impact factor: 1.925

8.  Colchicine in experimental alkaline burns of the rat esophagus: an old drug, a new indication?

Authors:  Vahit Yukselen; Enver Vardar; Ozden Yukselen; Ali Onder Karaoglu; Cigdem Yenisey; Omer Ozutemiz
Journal:  Pediatr Surg Int       Date:  2006-02-08       Impact factor: 1.827

9.  Enhanced effect of soluble transforming growth factor-beta receptor II and IFN-gamma fusion protein in reversing hepatic fibrosis.

Authors:  H Yao; J Pan; Y Qian; Z Pei; A Bader; N H Brockmeyer; P Altmeyer; Lihuang Zhang
Journal:  Eur J Med Res       Date:  2010-04-08       Impact factor: 2.175

Review 10.  Zinc and the liver: an active interaction.

Authors:  Ioannis Stamoulis; Grigorios Kouraklis; Stamatios Theocharis
Journal:  Dig Dis Sci       Date:  2007-04-06       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.